Stockscreener 앱 받기
55.00
0.87%
-0.48
시간 외 거래:
55.00
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Best Artificial Intelligence Stocks To ConsiderMay 3rd - MarketBeat
Why Tempus AI (TEM) Is Up 5.5% After Major USC Precision-Medicine Data Partnership News - Yahoo Finance
Hussman Strategic Advisors Inc. Purchases 21,000 Shares of Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks To Keep An Eye OnMay 2nd - MarketBeat
Tempus AI (TEM) Stock Named to TIME’s Most Influential Health Companies of 2026 - MEXC
Tempus AI (TEM) Stock Gains Recognition on TIME’s 2026 Health Influencer List - MEXC
Best Artificial Intelligence Stocks Worth WatchingMay 1st - MarketBeat
Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus - TechStock²
Tempus AI (TEM) Partners with Keck Medicine of USC to Integrate AI Across Healthcare Network - Insider Monkey
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock - MarketBeat
Tempus AI Faces Class Action Cases for Collection of Genetic Information in Acquisition - The National Law Review
TEM Stock Price Prediction 2025-2026 | Tempus AI, Inc. Class A Common Stock Forecast | 24/7 Wall St. - 24/7 Wall St.
Tempus AI(TEM.US) 10% Shareholder Sells US$8.5 Million in Common Stock - Moomoo
Tempus AI (TEM) CEO’s entities sell 166,250 shares under Rule 10b5-1 plan - Stock Titan
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? - Insider Monkey
5 Best Up and Coming Stocks with Highest Upside Potential - Insider Monkey
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now? - Yahoo Finance
Assessing Tempus AI (TEM) Valuation After A Recent Share Price Bounce - Yahoo Finance
Artificial Intelligence Stocks Worth WatchingApril 30th - MarketBeat
How The Tempus AI (TEM) Narrative Is Shifting Around Data, Partnerships And Growth Visibility - Yahoo Finance
Tempus AI Stock Surges on Fresh Recognition Buzz - TipRanks
Tempus AI’s TIME Honor And USC Deal Test Its Long Term Thesis - Yahoo Finance
Tempus to Host Inaugural Investor Day on May 29, 2026 - 01net
GC Wealth Management RIA LLC Invests $399.27 Million in Tempus AI, Inc. $TEM - MarketBeat
Bogart Wealth LLC Raises Stock Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI shares gain after expanded partnership with Gilead - MSN
Multiple Class A Common sales reported by holders (NASDAQ: TEM) - Stock Titan
Tempus AI (TEM) to Release Earnings on Tuesday - MarketBeat
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - Business Wire
TEM Stock Price, Quote & Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI (TEM) Proxy filing Summary - Quartr
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy? - The Globe and Mail
Tempus AI will acquire Paige for $81.25M - MSN
Tempus AI, Inc. $TEM Stake Cut by Renaissance Capital LLC - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Uncovering the Potential 38.91% Upside with Cutting-Edge Healthcare Technology - DirectorsTalk Interviews
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? - MSN
Guggenheim Maintains Tempus AI (TEM) Buy Recommendation - MSN
Artificial Intelligence Stocks To ConsiderApril 26th - MarketBeat
Tempus AI stock near 1-year low: Cathie Wood’s ARK buys more while offloading Nvidia, Meta, other tech plays - MSN
Can Tempus AI’s (TEM) USC Partnership Quietly Redefine Its Clinical Data Moat? - simplywall.st
Best Artificial Intelligence Stocks To Watch NowApril 25th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI Nears Profitability as Operating Leverage Emerges - The Globe and Mail
Artificial Intelligence Stocks To Watch NowApril 24th - MarketBeat
Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door - TechStock²
Tempus AI (TEM) Stock Drops 7% Despite Landmark USC Medical Partnership - MEXC Exchange
Tempus AI (TEM) Stock Slides Even As USC Inks Major AI Health Deal - MEXC
Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F - GlobeNewswire Inc.
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility? - Yahoo Finance
Tempus AI partners with USC’s Keck Medicine on precision care By Investing.com - Investing.com Australia
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine - BioSpace
9.61%
1.99%
자본화:
|
볼륨(24시간):